Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/67199
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

AutorBroen, Jasper C.; Bossini-Castillo, L.; Bon, Lenny van; Vonk, Madelon C.; Knaapen, Hanneke; Beretta, L.; Rueda, B.; Hesselstrand, R.; Herrick, A.; Worthington, J.; Hunzelmann, Nicolas; Denton, C.; Fonseca, C.; Riemekasten, G.; Kiener, H. P; Scorza, R.; Simeón, Carmen P.; Ortego-Centeno, N.; González-Gay, M. A.; Airó, Paolo; Coenen, M. J.; Martín, J.; Radstake, T. R.
Fecha de publicación2012
EditorJohn Wiley & Sons
CitaciónArthritis and Rheumatism 64: 264- 271 (2012)
ResumenObjective To investigate whether polymorphisms in Toll-like receptor (TLR) genes, previously reported to be associated with immune-mediated diseases, are involved in systemic sclerosis (SSc). Methods We genotyped 14 polymorphisms in the genes for TLRs 2, 4, 7, 8, and 9 in a discovery cohort comprising 452 SSc patients and 537 controls and a replication cohort consisting of 1,170 SSc patients and 925 controls. In addition, we analyzed 15-year followup data on 964 patients to assess the potential association of TLR variants with the development of disease complications. We analyzed the functional impact of the associated polymorphism on monocyte-derived dendritic cells. Results In the discovery cohort, we observed that a rare functional polymorphism in TLR2 (Pro631His) was associated with antitopoisomerase (antitopo) positivity (odds ratio 2.24 [95% confidence interval 1.24-4.04], P = 0.003). This observation was validated in the replication cohort (odds ratio 2.73 [95% confidence interval 1.85-4.04], P = 0.0001). In addition, in the replication cohort the TLR2 variant was associated with the diffuse subtype of the disease (P = 0.02) and with the development of pulmonary arterial hypertension (PAH) (Cox proportional hazards ratio 5.61 [95% confidence interval 1.53-20.58], P = 0.003 by log rank test). Functional analysis revealed that monocyte-derived dendritic cells carrying the Pro63His variant produced increased levels of inflammatory mediators (tumor necrosis factor α and interleukin-6) upon TLR-2-mediated stimulation (both P < 0.0001). Conclusion Among patients with SSc, the rare TLR2 Pro631His variant is robustly associated with antitopoisomerase positivity, the diffuse form of the disease, and the development of PAH. In addition, this variant influences TLR-2-mediated cell responses. Further research is needed to elucidate the precise role of TLR-2 in the pathogenesis of SSc. © 2012 by the American College of Rheumatology.
URIhttp://hdl.handle.net/10261/67199
DOI10.1002/art.33325
Identificadoresdoi: 10.1002/art.33325
issn: 0004-3591
Aparece en las colecciones: (IPBLN) Artículos

Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

70
checked on 06-mar-2024

WEB OF SCIENCETM
Citations

69
checked on 25-feb-2024

Page view(s)

465
checked on 18-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.